Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 19 Source: CRO
- €121.1 million turnover
-
-€17.6 million
profit - 186 employees
-
31st Dec 18 Source: CRO
- €161.4 million turnover
-
-€1.9 million
profit - 183 employees
- 8 more years available »
Ranking
By Turnover
(€121.1 million)- 454th in Top Companies
- 42nd in Pharma
By Employees
(186)- 627th in Top Companies
- 57th in Pharma
-
- 186
- €121.1 million
Employees
- Riccardo Braglia CEO/Managing Director
Latest News
- 5:15am Eir planning to sell almost half of Irish fibre network
- Oct 22 Methane leak near Cop26 venue underscores emissions challenge
- Oct 22 Goldman grants stock worth $30m in five years to chief David Solomon
- Oct 22 RDS hosts first large event since pandemic with return of Ideal Home Exhibition
- Oct 22 Ronan Group gets injunction preventing Digital Bridge selling Dublin stakes